Aldosterone/renin quotient
Material: | 1 ml serum (Aldosterone) and 1 ml EDTA plasma, frozen (Renin) |
Methods: | Ligandenassays → Chemilumineszenz-Immunoassay (CLIA) | Reference range | Please refer to findings report |
Indication | Suspicion of primary hyperaldosteronism |
Please note | Some antihypertensive drugs should be discontinued as far as clinically tenable: Beta blockers, centrally effective alpha-1 agonists (such as ebrantil) as well as nonsteroidal antirheumatics may lead to false positive results and should definitely be discontinued. Aldosterone receptor antagonists (spironolactone), ACE inhibitors, AT-1 inhibitors (sartans), calcium antagonists of the dihydropyridine type (amlodipine, nifedipine) and diuretics can lead to false negative results. Aldosterone receptor antagonists (4 weeks before) and loop diuretics (1 week before) should definitely be discontinued. All other antihypertensives may be continued, if discontinuation is not clinically tenable. Definite evaluation with these drugs however, is only possible in case of a positive result. Renin inhibitors (such as aliskiren) may lead to false negative as well as false positive results and should also be discontinued. Having large amounts of liquorice may also lead to falsification of the ARQ result. Whilst it is not an essential precondition, it is still the recommendation to test women during the first half of their menstrual cycle. |
Accredited | ja |
More Results for the letter A
- Angina Plaut-Vincenti (APV)
- Treponema vincentii and fusobacterium nucleatum
- ANP (ANP)
- atrial natriuretic peptide
- Anti-actin autoantibodies (ACTIN)
- Anti-alpha fodrin autoantibodies (AFODG)
- Anti-desmoglein 1/3 (DESMO)
- Anti-DNA antibodies (DNADS)
- ds-DNA antibodies (double-stranded)
- Anti-epidermal basal membrane (EPI)
- Anti-goblet cell autoantibodies (BECZE)
- Anti-mitochondrial antibodies (AMA)
- AMA and AMA subtype 2
- Anti-mullarian hormone (AMH)
- Anti-sickle cell desmosomes (STADE)
- Anti-SP100 (SP100)
- multiple nuclear dots
- Antibiogram (ANTIBIO)
- Antibodies against α-amino-3-hydroxy-5-methyl-4-isoxazol-propionic acid receptor (AMPAR)
- Antibodies against adenylate kinase 5 (Ak5)
- Ak5
- Antibodies against contactin-associated protein 2 (CASPR2)
- Antibodies against ganglionic (alpha-3) acetylcholine receptors (gAChR)
- (gAChR)
- Antibodies against glutamate decarboxylase 65 kDa (GAD65)
- Antibodies against leucine-rich glioma inactivated protein 1 (LGI1)
- Antibodies against LRP4
- (low-density lipoprotein receptor-related protein 4)
- Antibodies against myelin oligodendrocyte glycoprotein (MOG)
- Antibodies against N-methyl-D-aspartate receptor receptors (NMDAR)
- Antibodies against oxidized LDL (LDLOX)
- Antibodies against the γ-aminobutyric acid A receptor (GABA-A-R)
- Antibodies against the γ-aminobutyric acid B receptor (GABA-B-R)
- Antibodies against the glial fibrillary acidic protein (GFAP)
- Antibodies against the glycine receptor (GlyR)
- Antibodies against the metabotropic glutamate receptor type 1 (mGluR1 antibodies)
- Antibody screen (ANTI01)
- Antibody screening (AK)
- AKS